SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Munch-a-Biotech Today
An SI Board Since December 1998
Posts SubjectMarks Bans
3158 136 0
Emcee:  Biomaven Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2933Vertex a target for Gilead? The linked article is more about Gilead's challDoctor Zeus11/30/2011
2932A list of prey from Barrons (hat tip to Doug): siliconinvestor.com Cheers, Tutuck-1/29/2011
2931Size of P2 and caveats re cancer vaccines notwithstanding, I have to admit theirtuck-1/25/2011
2930We have been talking for DECADES about using GM-CSF as a cancer vaccine adjuvantscaram(o)uche-1/25/2011
2929I would agree. $0.5B for a failure sounds really expensive. Nevertheless $1.0B Ian@SI-1/25/2011
2928Not sure what AMGN is thinking with this one. Aside from the cancer vaccine isstuck-1/25/2011
2927Another private company munched... Amgen to acquire BioVex, a privately held biIan@SI-1/24/2011
2926GXDX by Novartis; <i>Shares of Genoptix Inc. jumped 26 percent in premarkSteve Lokness-1/24/2011
2925>>particularly where a large molecule could be a player...<< bloombnigel bates-1/11/2011
2924MATK munched this morning. 6:27AM Martek Biosci to be acquired by Royal DSM forIan@SI-12/21/2010
2923FOSTER CITY, Calif. & PALO ALTO, Calif.--(BUSINESS WIRE)-- Gilead Sciences, nigel bates-12/20/2010
2922CYPB agrees to a sweetened Ramius offer of $6.50/sh. Only headline news thus faBiotech Jim-12/15/2010
2921SmartCells attaches insulin to a biodegradable polymer which holds the insulin ikeokalani'nui-12/2/2010
2920Via Minyanville, Leerink's most recent picks for takeout: minyanville.com tuck-12/2/2010
2919Genzyme Mulls Its Deal Options By GINA CHON Ansim1-11/21/2010
2918Do yourself a favorite and check out Celldex Therapeutics (Nasdaq: CLDX) before Gator II-11/21/2010
2917Amgen Inc., the world’s largest biotechnology company, is considering a takeoverkeokalani'nui-11/17/2010
2916GENZ in talks with Takeda for $82. per share buyout. Termeer has set a goal of pgo-neil-11/14/2010
2915And what do shareholders get? <i>Tuesday, October 5, 2010 - ZymoGeneticsSteve Lokness-10/8/2010
2914And still shares going off at 9.76 this morning for ZGEN. Only a penny above buySteve Lokness-10/8/2010
2913Miller's adjustments for milestone payments and net cash involve apples-to-oDewDiligence_on_SI-10/8/2010
2912David Miller at Minyanville on BMY buyout of ZGEN... This article shows several pgo-neil-10/8/2010
2911Shrinking U.S. Biotechnology Sector Lost 25% of Companies in Past 3 Years By Rosim1-10/6/2010
2910DEALTALK-UPDATE 1-Savient's gout drug nod may trigger bid war Thomson ReuteIan@SI-9/21/2010
2909Cleveland BioLabs Inc. has been awarded a $45 million contract from the U.S. DepNikole Wollerstein-9/17/2010
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News